Overview

Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease

Status:
Terminated
Trial end date:
2016-08-04
Target enrollment:
Participant gender:
Summary
This study was designed to assess the safety, tolerability and efficacy of ACZ885 on the leg artery structure and physical activity in patients with atherosclerotic peripheral artery disease and leg pain from walking.
Phase:
Phase 2
Details
Lead Sponsor:
Novartis Pharmaceuticals